Mission Bay Capital LLC uses capital and expertise to help entrepreneurs emerging from the University of California change the world. We begin with the conviction that more of the creativity of the University of California can directly benefit society. Universities have an obligation to meet public needs for new sources of energy, new solutions for patients, and ultimately the formation of whole new industries.
MBC will help launch companies that meet these needs. Our success will redress social challenges, replenish future funds, and ultimately build a research and educational endowment for QB3 (California Institute for Quantitative Biosciences) to drive the development of the next generation of innovations.
Location: United States, California, San Francisco
Employees: 11-50
Founded date: 2009
Investors 1
Date | Name | Website |
- | Scientia V... | scientiavc... |
Mentions in press and media 10
Date | Title | Description | Source |
11.03.2024 | Nitrase Therapeutics Unveils Pioneering Antibody Candidate f... | -Nitrase’s first-in-class antibody found to significantly delay progression of Parkinson’s disease i... | svhealthin... |
22.07.2021 | Plant-based cheesemaker Nobell Foods nets $75m from a16z, Ag... | Disclosure: AFN’s parent company AgFunder is an investor in Nobell Foods. Alt-protein startup Nobell... | agfunderne... |
17.09.2019 | Life science-focused Mission Bay Capital raises $60m for Fun... | San Francisco-based VC Mission Bay Capital has raised $60m for the final close of its third early-st... | altassets.... |
16.09.2019 | Mission Bay Capital Closes Fund III, at $60M | Mission Bay Capital, a San Francisco, CA-based early-stage life-science venture capital firm investi... | finsmes.co... |
05.12.2017 | Asilomar Bio Raises $12m Series B for Chemical Yield Enhance... | Asilomar Bio, a San Francisco-based maker of chemical crop inputs has raised a $12.25 million Series... | agfunderne... |
08.09.2016 | Chrono Therapeutics raises $47.6M for smoking cessation wear... | The wearable also has a “crave” button users can press that records the moment they want a cigarette... | medcitynew... |
12.05.2015 | Mission Bay Capital Closes $25M Life Sciences Fund | Mission Bay Capital, LLC (MBC), a San Francisco, CA-based seed-stage venture firm investing in life ... | finsmes.co... |
20.05.2013 | eFFECTOR Therapeutics Completes $45M Series A Financing | eFFECTOR Therapeutics, a San Diego, CA-based newly formed biopharmaceutical company, completed a $45... | finsmes.co... |
20.05.2013 | eFFECTOR Therapeutics Raises $45 Million in Series A Financi... | eFFECTOR Therapeutics Raises $45 Million in Series A Financing Company to Focus on Small Molecule Se... | fiercebiot... |
- | Chrono Therapeutics raises $47.6M for smoking cessation wear... | Smoking cessation is a big priority for self-insured employer programs and payers, particularly sinc... | medcitynew... |